While there was a significant increase in MST in mice treated with combination therapy compared to those treated with WP1066 alone (p=0.027), the improvement in MST between mice treated with combination therapy versus anti-CD47 alone did not reach statistical significance (MST: 63 days vs 50 days, p =0.083).
← all excerpts
STAT3 inhibition in combination with CD47 blockade inhibits osteosarcoma lung metastasis.
1
0.0830
0.0830